Meet Jack Reynolds, CEO at BioLum Sciences #BioNTX
BioLum Sciences
生物技术研究
Dallas,Texas 566 位关注者
Transforming Precision Drug Discovery and Early Detection of Disease
关于我们
Leveraging biomarker analysis with an integrated approach, BioLum is transforming precision medicine and early disease detection. Our highly-sensitive, selective assays and lab services provide insights for more efficient therapeutic R&D. With a focus on reactive oxygen, nitrogen, and sulfur species (RONSS), BioLum's assays outperform gold standards (including Griess & DAF). Our advanced chemiluminescence improves signal-to-noise by eliminating background autofluorescence, ensuring superior accuracy and precision with broad specimen compatibility. We work with pharmaceutical companies and researchers through preclinical discovery and development. To optimize treatment efficacy in complex diseases, it's critical to have a deep understanding of signaling pathways, mechanisms of action, and cellular interactions. Capabilities and services: -biomarker analysis -compound library screening -efficacy testing -rapid evaluation methods -custom assay synthesis -small molecule synthesis -drug repurposing -quantitative and qualitative insights -early target identification and validation -ADME -dose dependency testing -in vitro analysis -PK/PD -formula optimization -probe synthesis and development Our assays are designed for HTS with clinical translation and ease-of-use in mind. Reactive species are implicated in a range of diseases, including inflammation, cardiovascular (CAD, HF, PAH), respiratory (asthma, COPD), neurological, pain, tumor microenvironments, and immune-related.
- 网站
-
https://www.biolumsciences.com/
BioLum Sciences的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Dallas,Texas
- 类型
- 私人持股
- 领域
- Disease biomarkers、Diagnostic & Personal Management、Biotechnology、COPD、Precision Medicine、Oxidative Stress、Nitric Oxide、Chemiluminescence、Assay Development、Pulmonary Arterial Hypertension、Heart Failure、Heart Disease、Cardiovascular、Drug Discovery、Assays、Reactive Species、PAH、Chronic Diseases、Inflammation、Assay Development、Cardiovascular、Respiratory、Dose Dependency和Cell Models
地点
-
主要
3060 Pegasus Park Dr
US,Texas,Dallas,75247
BioLum Sciences员工
动态
-
BioLum Sciences is proud to join the Advanced Research Projects Agency for Health (ARPA-H) Investor Catalyst Hub and Spoke Consortium! As a drug discovery and development CRO, we look forward to advancing health innovation alongside other new members: Battelle Berkshire Innovation Center Beth Israel Lahey Health Cimit As biomarkers and endpoints become even more critical in therapeutic development, we're eager to collaborate and bring our expertise in chemiluminescence and custom assay development to the forefront. Explore each spoke and submit your application to join the network: https://bit.ly/4atwMS7. VentureWell Advanced Research Projects Agency for Health (ARPA-H) #ARPANETH #MedTech #HealthTech #HealthInnovation
?? Let's extend a warm welcome to the newest members of the Investor Catalyst Hub spoke network: Battelle Berkshire Innovation Center Beth Israel Lahey Health BioLum Sciences CIMIT Explore each spoke and submit your application to join the network on our website: https://bit.ly/4atwMS7. Keep an eye out for upcoming introductions of additional network members in the days ahead! #ARPANETH #MedTech #HealthTech #HealthInnovation VentureWell Advanced Research Projects Agency for Health (ARPA-H)
-
-
Biotech incubators are paving the way for new start ups to take shape in innovation hotspots across the globe. In this blog, discover how BioLabs Pegasus Park - North Texas is sparking biotech innovation in North Texas. From plug-and-play labs to groundbreaking companies like BioLum Sciences, innovation thrives here. #CustomerSpotlight #LoveOfInnovation